The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Self-citationWen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,121
Brandes, A. A., Franceschi, E., Tosoni, A., Blatt, V., Pession, A., Tallini, G., Bertorelle, R., Bartolini, S., Calbucci, F., Andreoli, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8163 · Cited by 840
Pauleit, D. (2005) · Brain · doi:10.1093/brain/awh399 · Cited by 634
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
Hygino da Cruz, L. C., Rodriguez, I., Domingues, R. C., Gasparetto, E. L., & Sorensen, A. G. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2397 · Cited by 545
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Wester, H. J., Herz, M., Weber, W., et al. (1999) · PubMed · Cited by 466
Pseudoprogression and pseudoresponse in the treatment of gliomas
Brandsma, D., & van den Bent, M. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328332363e · Cited by 378
O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications
Langen, K.-J., Hamacher, K., Weckesser, M., Floeth, F., Stoffels, G., Bauer, D., Coenen, H. H., & Pauleit, D. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.01.002 · Cited by 316
Self-citationDunet, V., Rossier, C., Buck, A., Stupp, R., & Prior, J. O. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.096859 · Cited by 244
Asao, C., Korogi, Y., Kitajima, M., Hirai, T., Baba, Y., Makino, K., Kochi, M., Morishita, S., & Yamashita, Y. (2005) · PubMed Central · Cited by 237
Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-l-tyrosine
Hamacher, K., & Coenen, H. H. (2002) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00225-7 · Cited by 235
Galldiks, N., Langen, K.-J., Holy, R., Pinkawa, M., Stoffels, G., Nolte, K. W., Kaiser, H. J., Filss, C. P., Fink, G. R., Coenen, H. H., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098590 · Cited by 204
Self-citationFelsberg, J., Rapp, M., Loeser, S., Fimmers, R., Stummer, W., Goeppert, M., Steiger, H.-J., Friedensdorf, B., Reifenberger, G., & Sabel, M. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2801 · Cited by 203
Self-citationPotential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma
Young, R. J., Gupta, A., Shah, A. D., Graber, J. J., Zhang, Z., Shi, W., Holodny, A. I., & Omuro, A. M. P. (2011) · Neurology · doi:10.1212/wnl.0b013e31821d74e7 · Cited by 195
Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
Rapp, M., Heinzel, A., Galldiks, N., Stoffels, G., Felsberg, J., Ewelt, C., Sabel, M., Steiger, H. J., Reifenberger, G., Beez, T., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109603 · Cited by 193
Self-citationKong, D.-S., Kim, S. T., Kim, E.-H., Lim, D. H., Kim, W. S., Suh, Y.-L., Lee, J.-I., Park, K., Kim, J. H., & Nam, D.-H. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2286 · Cited by 192
Galldiks, N., Stoffels, G., Filss, C. P., Piroth, M. D., Sabel, M., Ruge, M. I., Herzog, H., Shah, N. J., Fink, G. R., Coenen, H. H., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.103325 · Cited by 190
Self-citationMangla, R., Singh, G., Ziegelitz, D., Milano, M. T., Korones, D. N., Zhong, J., & Ekholm, S. E. (2010) · Radiology · doi:10.1148/radiol.10091440 · Cited by 171
Galldiks, N., Rapp, M., Stoffels, G., Fink, G. R., Shah, N. J., Coenen, H. H., Sabel, M., & Langen, K.-J. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2251-4 · Cited by 171
Self-citationHutterer, M., Nowosielski, M., Putzer, D., Waitz, D., Tinkhauser, G., Kostron, H., Muigg, A., Virgolini, I. J., Staffen, W., Trinka, E., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086645 · Cited by 168
Self-citationHerholz, K., Langen, K.-J., Schiepers, C., & Mountz, J. M. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.06.001 · Cited by 164
Self-citationNew advances that enable identification of glioblastoma recurrence
Yang, I., & Aghi, M. K. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.150 · Cited by 153
Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients
Jansen, N. L., Suchorska, B., Wenter, V., Eigenbrod, S., Schmid‐Tannwald, C., Zwergal, A., Niyazi, M., Drexler, M., Bartenstein, P., Schnell, O., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.122333 · Cited by 141
Box, P. (2010) · International Journal of Medical Radiology · Cited by 140
Galldiks, N., Stoffels, G., Ruge, M. I., Rapp, M., Sabel, M., Reifenberger, G., Erdem, Z., Shah, N. J., Fink, G. R., Coenen, H. H., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123836 · Cited by 124
Self-citationCha, J., Kim, S. T., Kim, H.-J., Kim, B., Kim, Y. K., Lee, J. Y., Jeon, P., Kim, K. H., Kong, D., & Nam, D. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3876 · Cited by 117
Moulin-Romsee, G., D’Hondt, E., de Groot, T., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0557-4 · Cited by 91
Cited by
Albert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., la Fougère, C., Pope, W., Law, I., Arbizu, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now058 · Cited by 744
Self-citationLaw, I., Albert, N. L., Arbizu, J., Boellaard, R., Drzezga, A., Galldiks, N., la Fougère, C., Langen, K.-J., Lopci, E., Lowe, V., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4207-9 · Cited by 556
Self-citationAdvances in neuro-oncology imaging
Langen, K.-J., Galldiks, N., Hattingen, E., & Shah, N. J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.44 · Cited by 339
Self-citationSonni, I., Garibotto, V., Iagaru, A., Das, D., & Massoud, T. (2018) · PET/MRI in Oncology · doi:10.1007/978-3-319-68517-5_11 · Cited by 3
Metadata
- Authors
- Galldiks, N., Dunkl, V., Stoffels, G., Hutterer, M., Rapp, M., Sabel, M., Reifenberger, G., Kebir, S., Dorn, F., Blau, T., Herrlinger, U., Hau, P., Ruge, M. I., Kocher, M., Goldbrunner, R., Fink, G. R., Drzezga, A., Schmidt, M., & Langen, K.-J.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2014-11-20
- Volume
- 42
- Issue
- 5
- Pages
- 685-695
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2093711649
- Cited by
- 266
- References
- 30
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.